The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Chills 2
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Confusional state 2
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Diarrhoea 2
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Dizziness 2
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Dyspnoea 2
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Fall 2
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Gait disturbance 2
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Herpes zoster 2
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Hyponatraemia 2
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Hypotension 2
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Infection 2
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Mobility decreased 2
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Nausea 2
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Neutropenia 2
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Tachycardia 2
Rituximab Abasia 1
Rituximab Abdominal pain upper 1
rituximab Abortion induced 1
Rituximab Abscess intestinal 1
Rituximab Acetonaemic vomiting 1

Total Records: 1,104     Number of Pages: 56